Department of General and Emergency Surgery, Misericordia Hospital, School of Robotic Surgery (SRS), Grosseto, Italy.
Ann Surg Oncol. 2024 Jul;31(7):4693-4694. doi: 10.1245/s10434-024-15388-5. Epub 2024 May 6.
Central pancreatectomy (CP) is indicated for benign or low-grade pancreatic tumors located in the neck or proximal pancreatic body. This procedure is demanding and has a high rate of postoperative complications. Minimally invasive surgery is now commonly used for CP but it is still unclear whether the robotic approach offers any advantages over conventional pancreatic minimally invasive surgery. Most studies on robotic CP are limited to case reports or case series; however, there are two important studies on this topic. Currently, the evidence on robotic CP remains limited, making it challenging to draw definitive conclusions in favor of one technique over the other. The use of a robotic platform, with its integrated tools such as intraoperative ultrasound, can guide the surgeon in performing this technically demanding procedure in a safer manner. The controversy regarding the best minimally invasive surgery approach for CP is still ongoing and requires further research.
胰体中部切除术（CP）适用于位于颈部或胰体近端的良性或低级别胰腺肿瘤。该手术难度大，术后并发症发生率高。微创外科技术现在常用于 CP，但机器人辅助微创胰体中部切除术是否优于传统的胰腺微创外科技术仍不清楚。大多数关于机器人 CP 的研究仅限于病例报告或病例系列，但有两项关于该主题的重要研究。目前，关于机器人 CP 的证据仍然有限，因此很难得出有利于一种技术而不是另一种技术的明确结论。机器人平台的使用，及其集成的工具，如术中超声，可以指导外科医生更安全地进行这项技术要求高的手术。关于 CP 的最佳微创外科方法的争议仍在继续，需要进一步的研究。
